Published online Mar 14, 2025. doi: 10.3748/wjg.v31.i10.103973
Revised: January 24, 2025
Accepted: February 11, 2025
Published online: March 14, 2025
Processing time: 82 Days and 22.3 Hours
Echinococcosis or hydatid disease is induced mainly by Echinococcus granulosus and occasionally by Echinococcus multilocularis (alveolaris) and affects the liver predominantly. Hepatic alveolar echinococcosis is similar to carcinoma in appea
Core Tip: The most common cystic hepatic echinococcosis has a chronic course. Proper elective surgical management or emergency complications is mandatory to ensure good outcomes and a permanent cure. Attention must be given to the early diagnosis of alveolar echinococcosis as surgery can be successful at the initial stage. Otherwise, albendazole treatment is indicated in the final stage.
- Citation: Pavlidis ET, Galanis IN, Pavlidis TE. Current considerations for the management of liver echinococcosis. World J Gastroenterol 2025; 31(10): 103973
- URL: https://www.wjgnet.com/1007-9327/full/v31/i10/103973.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i10.103973
We read the paper by Tao et al[1] with great interest, and we would like to congratulate the authors for their excellent comprehensive work that reports precisely the role of ultrasonography as the first step in diagnosing liver echinococcus cysts.
Echinococcosis, otherwise known as hydatid disease, is a zoonotic disease that in the vast majority of individuals (95%) is induced by the tapeworm Echinococcus granulosus, which mainly parasitizes the gut of dogs, but in some instances, can also be caused by the tapeworm Echinococcus alveolaris (multilocularis), which is found mainly in the gut of foxes. Humans, sheep, cattle or pigs (intermediate hosts) are infected by the eggs of the parasite via food or water contaminated by the stool of dogs, wolves or foxes (the main hosts). The main hosts are infected by consuming the livers of the intermediate host containing echinococcus cysts[2-4].
Despite progress in reducing its incidence by improving sanitary conditions to stop the echinococcus cycle, it is still endemic in some countries (e.g., in the Mediterranean, Middle East, South America, Oceania, Africa, and Southeast Asia). Necessary preventive measures include thorough washing of fruits, adequate boiling of greens and vegetables, slaughter of animals in modern organized slaughterhouses and a sanitary burial of infected animals and their entrails. The liver is affected in most cases (70%-80%). The cysts are usually solitary (80%) and affect the right lobe. Other less common sites include the lungs (15%), spleen, kidneys, brain and other unusual locations in the body[3-5].
Typically, Echinococcus granulosus infection progresses through a long, usually asymptomatic course, and the cyst is discovered incidentally[6,7]; however, complications can sometimes occur as an emergency setting[8]. The most common complication is rupture into the biliary tree, which manifests as acute cholangitis[6], followed by rupture into the peritoneal cavity or occasionally the thoracic cavity, which manifest as anaphylactic shock[9]. Another complication is echinococcus cyst suppuration and abscess formation, which manifests as sepsis[10].
Alveolar echinococcus is an unusual infection that predominates in northern and central Europe, mainly in Switzerland, Russia, China, Alaska, Canada, and Japan, and without treatment, it can lead to portal hypertension, liver cirrhosis and ultimately, the death; there are reported instances of it being misdiagnosed as hepatocellular carcinoma[11-14]. When alveolar hepatic echinococcosis is accompanied by lymph node metastasis (8.5%), hepatectomy with lymph node clearance will be required if possible[15].
The following methods are used for diagnosis and follow-up: Ultrasound (US), with a diagnostic accuracy of up to 90%[11,16,17]; intraoperative US[18]; computed tomography (CT), with high sensitivity (94%) and specificity above 95%[19,20]; and magnetic resonance imaging (MRI)/cholangiopancreatography, with high sensitivity (96%) and specificity (98%)[17]. In ambitious cases, serum specific anti-echinococcal antibodies, i.e., IgG and IgM, may be valuable. US is the first step in detecting the disease in clinical practice[1]. Multidetector CT is the best tool for venous invasion assessment in alveolar echinococcus, which is common, as well as for assessing bile duct invasion[21]. MRI is used to evaluate the detailed characteristics and appearance of hydatid cysts, as well as any communication of the cyst with the biliary tree, which is a prerequisite for developing an operative plan[17]. US, CT or MRI may be used to evaluate the imaging characteristics of alveolar echinococcosis, contributing to the diagnosis, staging and follow-up; in addition, these methods can provide guidance for percutaneous palliative interventions in inoperable cases[22].
In biliary rupture, emergency endoscopic retrograde cholangiopancreatography with sphincterotomy and bile duct clearance is necessary[23,24]. Additionally, ERCP is valuable in the diagnosis and management of postoperative biliary fistulas, including occult[25,26] and bile leaks[24,27].
Management is stratified on the basis of the etiological agent (E. granulosus vs E. multilocularis), and the options include surgery, percutaneous methods and conservative oral drug therapy (albendazole, mebendazole and praziquantel). The World Health Organization classification may be useful for choosing the best treatment and follow-up methods[2,14,28]. Surgical resection may provide permanent treatment and is the most preferable option worldwide, whereas the use of interventional percutaneous methods is limited since they are accompanied by more complications and recurrences than excision surgery is. However, these methods are a good alternative choice for high-risk patients who are not amenable to surgery[2,14].
Surgery is the cornerstone of any therapeutic effort in cystic echinococcosis, particularly in solitary large cysts[3,17,29,30], even in the elderly[31]. Operative management concerns include the need for more complicated radical operations preferably, such as total pericystectomy[32-34] and hepatectomy[4,33,35,36], or the need for simpler, classical operations, e.g., cyst evacuation, partial cystectomy, and drainage or omentoplasty[6,17,33]. Intact cyst excision, despite the difficulty of the procedure, ensures a permanent cure and preservation of the hepatic parenchyma along with the avoidance of residual cavity complications; thus, it should be the first choice[32]. Laparoscopic or robotic surgery has gained popularity in recent years because of the advantages of minimally invasive surgery[6,7,33,37,38]. The use of indocyanine green fluorescence ensures better robotic imaging[39].
Percutaneous methods, including the puncture, aspiration, injection, reaspiration (PAIR) method combined with intracystic scolicocidal agent injection of alcohol or hypertonic saline[6,32,37,40,41] of equivalent efficacy[42] and its modification (Örmeci technique) by injection of alcohol and polidocanol[43], have been used as an alternative to surgery for cystic echinococcosis. Percutaneous drainage in combination with oral albendazole and praziquantel has been proposed to avoid PAIR-related toxic alcohol cholangitis if an occult cysto-biliary fistula exists or if life-threatening hypernatremia from hypertonic saline use occurs[44]. The complications of PAIR include cyst rupture, anaphylactic reactions, recurrence[6,32,40,43], toxic cholangitis, life-threatening hypernatremia[44], and residual cavity[37] or abscess formation[41]. Standard catheterization is recommended for treating cysto-biliary fistulas or avoiding abscess formation[41]. The recurrence rate was reported to be between 4.5%[40] and 20%[32]. The complication rate was reported to be 19.5% for ethanol injection and 13.5% for hypertonic saline injection[42].
Hepatectomy is the main management method for early-stage alveolar echinococcosis. Surgical resection, preferably in combination with the newest drug therapy, albendazole, or the older drug therapy, mebendazole, is recommended, but a disadvantage of drug therapy is hepatotoxicity[11,12]. Unfortunately, the disease is usually diagnosed at a late stage in patients with final portal hypertension and cirrhosis; thus, therapeutic excision is not possible[11]. However, for advanced-stage liver alveolar echinococcosis, hepatectomy accompanied by two-step vascular exclusion and in situ hypothermic portal perfusion has recently been performed in some very difficult cases. Although this major operation includes resection and reconstruction of the portal vein, inferior vena cava and hepatic veins, it has been proposed to be safe and effective[45]. Similarly, ex vivo hepatectomy and autotransplantation have recently been performed[46,47] in combination with inferior vena cava reconstruction[48].
Microwave ablation under US guidance has been used recently with promising results for the management of alveolar echinococcosis in some difficult cases[49] or in early-stage patients in combination with albendazole[50] as an alternative to surgery.
There are new drugs that can be combined with albendazole for treating alveolar echinococcosis, i.e., inhibitors of leucine aminopeptidase (ubenimex) antibiotics (clarithromycin, intraconazole, amphotericin b), immunosuppressants (interferon, cyclosporine), antineoplastics (imatinib, 5-fluorouracil, bortezomib, paclitaxel, tamoxifen) and antiangiogenic factors (sorafenib, anacardic acid), all of which have been tested in in vitro studies, with limited data from clinical trials but promising results from preliminary research[11].
Albendazole, which has almost completely replaced mebendazole, is recommended for patients with small cysts (less than 5 cm in size) or multiple cysts but without calcification. Treatment with albendazole prevents the need for surgical intervention as well as recurrence after surgery. It is required in the management of most cases of alveolar echinococcosis[4]. However, prolonged drug use is related to hepatotoxicity and bone marrow suppression[11].
Percutaneous drainage and oral albendazole may improve the quality of life in patients with alveolar echinococcosis who are not amenable to surgery[51]. The dose of albendazole is 10 mg/kg body weight/day per oral. The scheme usually includes one 400 mg tablet twice daily for a period of four weeks, followed by a two-week break, and then this cycle is repeated until 3 to 6 cycles are completed[52]. The addition of a single dose of praziquantel at 40 mg/kg body weight/day per oral twice a week for 4 weeks, followed by a break and then restarting, similar to the protocol for albendazole, increases the therapeutic efficacy of albendazole[28]. Liver function tests and blood white cell count monitoring are necessary during therapy to avoid potential toxicity[11].
In conclusion, surgery is the main management option for hepatic echinococcosis. Radical operations such as total pericystectomy or hepatectomy offer a permanent cure and should be the first choice for the most common type of cystic echinococcosis. Hepatectomy is recommended for early-stage alveolar disease, but it has also been attempted recently for advanced-stage alveolar disease. Albendazole has an important role in conservative management.
1. | Tao Y, Wang YF, Wang J, Long S, Seyler BC, Zhong XF, Lu Q. Pictorial review of hepatic echinococcosis: Ultrasound imaging and differential diagnosis. World J Gastroenterol. 2024;30:4115-4131. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
2. | Kuehn R, Uchiumi LJ, Tamarozzi F. Treatment of uncomplicated hepatic cystic echinococcosis (hydatid disease). Cochrane Database Syst Rev. 2024;7:CD015573. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
3. | A JD, Chai JP, Jia SL, A XR. Historical changes in surgical strategy and complication management for hepatic cystic echinococcosis. World J Gastrointest Surg. 2023;15:1591-1599. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 4] [Reference Citation Analysis (0)] |
4. | Pavlidis ET, Symeonidis N, Psarras K, Pavlidis TE. Huge echinococcal cyst of the liver managed by hepatectomy: Report of two cases. Int J Surg Case Rep. 2017;31:79-82. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
5. | Kendyala S, Narayanan R. Encysted Odyssey: A Clinical and Pictorial Analysis of Hydatid Cysts From Head to Toe. Cureus. 2024;16:e61180. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
6. | Azizoğlu M, Aydogdu B, Kamci TO, Arslan S, Basuguy E, Bilici S, Okur MH. Analysis of Complications of a Neglected Disease: 13 Years of Experience with Liver Hydatid Cysts in a High-Volume Hospital. Medicina (Kaunas). 2024;60. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
7. | Shabani M, Behnam F, Akbari H, Eidy M. Comparison of the frequency of complications resulting from open and laparoscopic surgery for hydatid cyst. Asian J Endosc Surg. 2025;18:e13391. [PubMed] [DOI] [Full Text] [Cited in This Article: ] |
8. | Shaprinskiy V, Verba A, Formanchuk T, Formanchuk A, Chernychenko O. Surgical treatment of echinococcosis of the liver and its complications. Wiad Lek. 2022;75:244-250. [PubMed] [Cited in This Article: ] |
9. | Koenders EE, Schoeber N, Koffeman EC, Jens S, Mauritz GJ. [Anaphylaxis due to traumatic rupture of an echinococcal cyst]. Ned Tijdschr Geneeskd. 2022;166. [PubMed] [Cited in This Article: ] |
10. | Hassan KS. A novel method for treatment of pseudomonas pyogenic hepatic abscess complicating an echinococcal cyst by irrigation with acetic acid. A case report and literature review. IDCases. 2021;25:e01186. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in Crossref: 1] [Reference Citation Analysis (0)] |
11. | Jing QD, A JD, Liu LX, Fan HN. Current status of drug therapy for alveolar echinococcosis. World J Hepatol. 2024;16:1243-1254. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 2] [Reference Citation Analysis (2)] |
12. | Autier B, Robert-Gangneux F, Dion S. Chemotherapy for the treatment of alveolar echinococcosis: Where are we? Parasite. 2024;31:56. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
13. | Gauthiez E, Uldry E, Coste AT, Prior J, Cavassini M, Munting A. [2023 update on alveolar echinococcosis]. Rev Med Suisse. 2023;19:708-712. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
14. | Denzinger M, Nasir N, Steinkraus K, Michalski C, Hüttner FJ, Traub B. [Treatment concepts for hepatic echinococcosis]. Chirurgie (Heidelb). 2023;94:560-570. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
15. | Aimaitijiang Y, Jiang TM, Shao YM, Aji T. Fifty-five cases of hepatic alveolar echinococcosis combined with lymph node metastasis: A retrospective study. World J Gastroenterol. 2024;30:2981-2990. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 2] [Reference Citation Analysis (4)] |
16. | Shang F, Song T, Wang Z, Wu M, Yan C, Wang X. Clinical Application of Artificial Intelligence in the Ultrasound Classification of Hepatic Cystic Echinococcosis. Am J Trop Med Hyg. 2024;111:93-101. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
17. | Berto CG, Liou P, Coyle CM, Emond JC. Surgical management of cystic echinococcosis of the liver. Curr Opin Infect Dis. 2023;36:348-352. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
18. | Trigui A, Toumi N, Fendri S, Saumtally MS, Zribi I, Akrout A, Mzali R, Ketata S, Dziri C, Amar MB, Boujelbene S. Cystic Echinococcosis of the Liver: Correlation Between Intra-Operative Ultrasound and Pre-Operative Imaging. Surg Infect (Larchmt). 2024;25:213-220. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
19. | Nijiati M, Tuerdi M, Damola M, Yimit Y, Yang J, Abulaiti A, Mutailifu A, Aihait D, Wang Y, Zou X. A deep learning radiomics model based on CT images for predicting the biological activity of hepatic cystic echinococcosis. Front Physiol. 2024;15:1426468. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
20. | Wang Z, Bian H, Li J, Xu J, Fan H, Wu X, Cao Y, Guo B, Xu X, Wang H, Zhang L, Zhou H, Fan J, Ren Y, Geng Y, Feng X, Li L, Wei L, Zhang X. Detection and subtyping of hepatic echinococcosis from plain CT images with deep learning: a retrospective, multicentre study. Lancet Digit Health. 2023;5:e754-e762. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Cited by in Crossref: 1] [Reference Citation Analysis (0)] |
21. | Zhang T, Zhang Y, Wang J, Hou J, Liu W. Multidetector computed tomography assessment of venous invasion in hepatic alveolar echinococcosis. Abdom Radiol (NY). 2023;48:297-305. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
22. | Aydin S, Irgul B, Memis KB, Kızılgoz V, Kantarci M. Characteristics of the imaging diagnosis of alveolar echinococcosis. World J Gastrointest Surg. 2024;16:2748-2754. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
23. | Ma J, Yan Q, Zha Xi Yun Dan, Hou Y, Tang R. Cystic hepatic echinococcosis with intrabiliary rupture. Hepatobiliary Surg Nutr. 2024;13:573-574. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Reference Citation Analysis (0)] |
24. | Couzens-Bohlin K, Krige JEJ, Malherbe J, Kotze UK, Khan R, Jonas E. The role of endoscopic retrograde cholangiopancreatography in the treatment of hepatic cystic Echinococcus in a high HIV prevalence population: a retrospective cohort study. S Afr J Surg. 2024;62:58-62. [PubMed] [Cited in This Article: ] |
25. | Calu V, Enciu O, Toma EA, Pârvuleţu R, Pîrîianu DC, Miron A. Complicated Liver Cystic Echinococcosis-A Comprehensive Literature Review and a Tale of Two Extreme Cases. Tomography. 2024;10:922-934. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
26. | Trigui A, Fendri S, Akrout A, Trabelsi J, Daoud R, Saumtally MS, Ketata S, Baklouti S, Boujelbene W, Mzali R, Dziri C, Rejab H, Boujelbene S. Predictive factors of occult cystobiliary fistulas during conservative treatment of hepatic hydatid cyst: a prospective study. J Gastrointest Surg. 2024;28:108-114. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
27. | Abbasi Dezfouli S, El Rafidi A, Aminizadeh E, Ramouz A, Al-Saeedi M, Khajeh E, Mieth M, Weber TF, Chang DH, Hoffmann K, Büchler MW, Mehrabi A. Risk factors and management of biliary leakage after Endocystectomy for hepatic cystic echinococcosis. PLoS Negl Trop Dis. 2023;17:e0011724. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
28. | Popova G, Vuchev D, Anichina K. Treatment of hepatic and pulmonary hydatidosis with albendazole and praziquantel. Helminthologia. 2023;60:221-226. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Reference Citation Analysis (0)] |
29. | Jaén-Torrejimeno I, Ramia JM, López-Guerra D, Rojas-Holguín A, De-Armas-Conde N, Blanco-Fernández G. Textbook outcome in the surgical treatment of liver hydatid cyst. Surgery. 2023;173:429-434. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
30. | Farhat W, Ammar H, Rguez A, Harrabi F, Said MA, Ghabry L, Gupta R, Ben Cheikh A, Ghali H, Ben Rajeb M, Ben Mabrouk M, Ben Ali A. Radical versus conservative surgical treatment of liver hydatid cysts: A paired comparison analysis. Am J Surg. 2022;224:190-195. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in RCA: 3] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
31. | Jaén-Torrejimeno I, López-Guerra D, Rojas-Holguín A, De-Armas-Conde N, Blanco-Fernández G. Surgical treatment of liver hydatid cyst in elderly patients: A propensity score-matching retrospective cohort study. Acta Trop. 2022;232:106466. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
32. | Daduk Y, Seker A, Sozutek A, Olmez T, Kaplan K, Dur H, Ozdemir G. Treatment Options and the Management of Complications in Hydatid Cysts of the Liver in Endemic Regions. Ann Ital Chir. 2024;95:213-219. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
33. | Elmoghazy W, Alqahtani J, Kim SW, Sulieman I, Elaffandi A, Khalaf H. Comparative analysis of surgical management approaches for hydatid liver cysts: conventional vs. minimally invasive techniques. Langenbecks Arch Surg. 2023;408:320. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in RCA: 8] [Article Influence: 4.0] [Reference Citation Analysis (0)] |
34. | Pavlidis ET, Symeonidis NG, Psarras KK, Martzivanou EK, Marneri AG, Stavrati KE, Pavlidis TE. Total cysto-pericystectomy for huge echinococcal cyst located on hepatic segment IVb. Case report and review of the literature. J Surg Case Rep. 2021;2021:rjab002. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Reference Citation Analysis (0)] |
35. | Aji A, Abulizi A, Ma H, Ahan A, Jiang T, Zhang R, Guo Q, Shao Y, Aji T, Shalayiadang P. Efficiency of Anatomical Hepatectomy in the Treatment of Hepatic Cystic Echinococcosis. Surg Infect (Larchmt). 2024;25:674-681. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
36. | Ortiz De Elguea-Lizarraga JI, Koi A, Stevenson HL, Bilek JM, Gosnell J, Wilhelm AB, McLellan S, Kueht ML. Liver Resection for Cystic Echinococcosis: Emergence of a Non-endemic Disease. Am Surg. 2023;89:6356-6358. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
37. | Yakubov FR, Sapaev DS. Surgical treatment of liver echinococcosis. J Med Life. 2022;15:1409-1414. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
38. | Wan L, Wang T, Cheng L, Yu Q. Laparoscopic Treatment Strategies for Liver Echinococcosis. Infect Dis Ther. 2022;11:1415-1426. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
39. | Zhang J, Li Y, Chen X, Wang J. Robot-assisted pericystectomy using Da Vinci Xi surgical system with indocyanine green fluorescence imaging for hepatic cystic echinococcosis. Asian J Surg. 2023;46:417-423. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
40. | Nagasbekov M, Baimakhanov Z, Doskhanov M, Nurlanbayev E, Kaniyev S, Akhan O, Baimakhanov B, Fakhradiyev I. Cystic echinococcosis of the liver in Kazakhstan: The effectiveness of the PAIR method in comparison with laparoscopic and open surgical methods. Asian J Surg. 2024;47:4711-4716. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
41. | Akhan O. Percutaneous treatment of liver hydatid cysts: to PAIR or not to PAIR. Curr Opin Infect Dis. 2023;36:308-317. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |
42. | Kayalı A, Uğur M. Comparison of ethanol and hypertonic saline as a single ıntracystic agent in the percutaneous treatment of liver hydatid cysts. Abdom Radiol (NY). 2023;48:1148-1153. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
43. | Örmeci N, Asiller ÖÖ, Parmaksız A, Kalkan Ç, Üstüner E, Altınel A, Erdem H. Percutaneous Treatment of Hydatid Cysts with the Örmeci Technique. Turk J Gastroenterol. 2024;35:398-407. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
44. | Richter J, Lindner AK, Geisel D, Fleckenstein FN, Torsello GF, Millet Pascual-Leone B, Ivanov O, Zöllner C, Wilde AB, Equihua Martinez G. Percutaneous drainage and combined praziquantel-albendazole therapy: a novel approach for the treatment of simple echinococcal liver cysts. Z Gastroenterol. 2024;62:500-507. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
45. | You X, Zuo B, Jiang J, Cheng D, Li P, Xing H, Yang C, Zhang Y. Liver resection with two-step vascular exclusion, in situ hypothermic portal perfusion for the treatment of end-stage hepatic alveolar echinococcosis. Langenbecks Arch Surg. 2024;409:168. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
46. | Joliat GR, Roulin D, Labgaa I, Uldry E, Demartines N, Halkic N, Melloul E. [Novelties on the management of alveolar echinococcosis]. Rev Med Suisse. 2023;19:1192-1195. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
47. | Mamuti A, Tulading A, Zhang YF, Azhati Y, Tuersunmaimaiti A, Maimaiti M, Lv CH, Wu J, Yao G, Aierken A, Tuxun T. Insight into the history and trends of liver transplantation for echinococcosis: A bibliometric analysis. World J Hepatol. 2024;16:1493-1504. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
48. | Maimaitinijiati Y, AJi T, Jiang TM, Ran B, Shao YM, Zhang RQ, Guo Q, Wang ML, Wen H. Approaches to reconstruction of inferior vena cava by ex vivo liver resection and autotransplantation in 114 patients with hepatic alveolar echinococcosis. World J Gastroenterol. 2022;28:4351-4362. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 4] [Reference Citation Analysis (0)] |
49. | Huang W, Hu Z, Qi L, Zhang X, Li M, Yu M, Hua G. Efficacy of percutaneous microwave ablation guided by contrast-enhanced and two-dimensional ultrasound for in hepatic alveolar echinococcosis in difficult/dangerous locations. Front Med (Lausanne). 2024;11:1436753. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Reference Citation Analysis (0)] |
50. | A J, Chai J, Shao Z, Zhao S, Wang H, A X, Yang J. Comparison of local ablation with Albendazole or laparoscopic hepatectomy combined with Albendazole in the treatment of early hepatic alveolar echinococcosis. Front Public Health. 2022;10:960635. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
51. | Eren S, Aydın S, Kantarci M, Kızılgöz V, Levent A, Şenbil DC, Akhan O. Percutaneous management in hepatic alveolar echinococcosis: A sum of single center experiences and a brief overview of the literature. World J Gastrointest Surg. 2023;15:398-407. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited in This Article: ] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
52. | Buscemi C, Randazzo C, Buscemi P, Caldarella R, Lombardo M, Buscemi S. Very Prolonged Treatment with Albendazole of a Case of Disseminated Abdominal Cystic Echinococcosis. Trop Med Infect Dis. 2023;8. [RCA] [PubMed] [DOI] [Full Text] [Cited in This Article: ] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |